Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-13-430499
Filing Date
2013-11-07
Accepted
2013-11-06 17:40:53
Documents
2
Group Members
BURRILL & CO (INDIANA GP), LLCBURRILL & CO (LIFE SCIENCES GP), LLCBURRILL & COMPANY, LLCBURRILL INDIANA LIFE SCIENCES CAPITAL FUND, L.P.G. STEVEN BURRILL

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G d623196dsc13ga.htm SC 13G/A 117334
2 EX-7.1 d623196dex71.htm EX-7.1 2446
  Complete submission text file 0001193125-13-430499.txt   121450
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-246-6400
diaDexus, Inc. (Subject) CIK: 0001036968 (see all company filings)

EIN.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-56525 | Film No.: 131197665
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address ONE EMBARCADERO CENTER SUITE 2700 SAN FRANCISCO CA 94111 415-591-5400
BURRILL LIFE SCIENCES CAPITAL FUND LP (Filed by) CIK: 0001204411 (see all company filings)

EIN.: 000000000
Type: SC 13G/A